Author/Authors :
Hajheydari، Zohreh نويسنده Department of Dermatology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari Hajheydari, Zohreh , Shahmohammadi، Soheila نويسنده Journal of Pediatrics Review Office, Mazandaran University of Medical Sciences, Sari Shahmohammadi, Soheila , Talaee، Rezvan نويسنده Department of Dermatology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan Talaee, Rezvan
Abstract :
Infantile Haemangiomas (IH) are the most common vascular tumors
occurring in early childhood, with a prevalence of approximately 5-
10% of infants. These vascular tumors are divided into two main
groups including; infantile haemangioma and vascular malformations.
Although, haemangioma of infancy are common, benign and selflimited
tumors, a significant percent of these lesions are associated with
substantial morbidity in infancy and childhood.
All currently used treatments have significant risks. Dramatic
improvement of complicated haemangioma of infancy to propranolol
was recently reported.
Here in, we review infantile haemangioma as a whole with focus on the
therapeutic efficacy of systemic and topical propranolol as a betablockers
for the management of infantile haemangioma.
